University of Miami
Coral Gables, Florida, 33143, United States
NCT Number: NCT02095327
The purpose of our study is to better understand how caregivers of individuals with dementia cope with their family member's illness. If you are eligible for the study and would like to participate, we will schedule a one-time phone interview, which will last approximately 2 hours for which you will be compensated for your time.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Coral Gables, Florida, 33143, United States
Eventually, results of this study will be used to develop treatments that will hopefully help caregivers cope more effectively with managing dementia in a loved one.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 3 months
Measured continuously using the Depression, Anxiety and Stress Scale on a scale of 1 - 56.
Time frame: 3 months
Measured continuously on the Depression, Anxiety, and Stress Scale on a scale of 1 - 56.
University of Miami
Other
Religion and Free Will Perceptions as Coping Mechanisms in Caregivers of Individuals With Dementia
Acronym: FAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details